Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2012 Oct;17(19-20):1088-102. doi: 10.1016/j.drudis.2012.05.007. Epub 2012 May 22.

Drug discovery in pharmaceutical industry: productivity challenges and trends.

Author information

  • Kareus Therapeutics, 40 Rue Fritz Courvoisier, 2300 La Chaux-de-Fonds, Switzerland. ikhanna@kareustherapeutics.com

Abstract

Low productivity, rising R&D costs, dissipating proprietary products and dwindling pipelines are driving the pharmaceutical industry to unprecedented challenges and scrutiny. In this article I reflect on the current status of the pharmaceutical industry and reasons for continued low productivity. An emerging 'symbiotic model of innovation', that addresses underlying issues in drug failure and attempts to narrow gaps in current drug discovery processes, is discussed to boost productivity. The model emphasizes partnerships in innovation to deliver quality products in a cost-effective system. I also discuss diverse options to build a balanced research portfolio with higher potential for persistent delivery of drug molecules.

Copyright © 2012 Elsevier Ltd. All rights reserved.

PMID:
22627006
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk